ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

NanoLogix, Inc. 

843 North Main Street

Hubbard  Ohio  44425  U.S.A.
Phone: 330-534-0800 Fax: 330-534-0826


SEARCH JOBS


Industry
Biotechnology






 Company News
NanoLogix, Inc. (NNLX) to Exhibit at Food Safety Summit in Baltimore and American Society for Microbiology Annual Meeting in Denver 4/30/2013 6:57:53 AM    More...
University of Texas Health Science Center at Houston Releases News of Successful NanoLogix, Inc. (NNLX) Test 3/12/2013 9:31:18 AM    More...
NanoLogix, Inc. (NNLX) Rapid TB Detection Results Published in Journal of Microbial & Biochemical Technology 12/17/2012 9:56:30 AM    More...
NanoLogix, Inc. (NNLX) Rapid Diagnostic Technologies Set to Enter Market Under FDA 510K-Exempt Status 8/21/2012 9:31:02 AM    More...
NanoLogix, Inc. (NNLX) Featured in USA Today Group B Streptococcus (GBS) Awareness Campaign 8/1/2012 12:01:07 PM    More...
NanoLogix, Inc. (NNLX) Announces Development of Multi-Well, Rapid Diagnostic Test Variant and Exhibits at the American Society for Microbiology General Meeting in San Francisco 6/13/2012 10:23:21 AM    More...
NanoLogix, Inc. (NNLX) Provides Testing and Operations Update 4/24/2012 10:17:31 AM    More...
NanoLogix, Inc. (NNLX) Provides Testing and Operations Update 4/24/2012 9:32:39 AM    More...
NanoLogix, Inc. (NNLX) Instructs Third-Party to Prepare US FDA Submittals and is Granted US and Chinese Patents 1/10/2012 10:08:52 AM    More...
NanoLogix, Inc. (NNLX) Technology Delivers Live Tuberculosis (TB) Detection Results in a Revolutionary 4 Days Versus Traditional 21 Days 11/1/2011 6:42:39 AM    More...
1234567